Organon: Achieving 8% Yield By 2024 – What To Look For
🌥️Trending News ORGANON ($NYSE:OGN) is a large international pharmaceutical company that has been providing innovative medicines and solutions to improve [...]
EU Begins Review of Bristol Myers’ Augtyro Cancer Therapy
🌧️Trending News BRISTOL-MYERS ($NYSE:BMY): Bristol Myers Squibb is a global biopharmaceutical company headquartered in New York City, United States. The [...]
Investors Take Closer Look at AbbVie’s Short Interest
☀️Trending News ABBVIE ($NYSE:ABBV): Investors around the world are closely monitoring AbbVie Inc. (ABBV), a research-based biopharmaceutical company that develops [...]
Scilex Holding Stock Fair Value – Scilpex Holding Company Reports Estimated Gross Sales of $150-155M for FY Ended Dec 31
🌧️Trending News Scilpex Holding Company, a leading pharmaceutical company, recently reported estimated gross sales of $150-155 million for the fiscal [...]
Gilead Sciences: A Look Ahead to 2024
🌥️Trending News Gilead Sciences ($NASDAQ:GILD) is an American biopharmaceutical company whose mission is to discover, develop, and commercialize innovative therapeutics. [...]
ELI LILLY & Co. Anticipates Key Debate Themes for 2024 Industrial Landscape
🌥️Trending News Eli ($NYSE:LLY) Lilly and Company is a global pharmaceutical leader that produces innovative medicines to improve outcomes for [...]
J&J Hopes for EPS Growth in 2024 to Reverse Losses, Talc Litigation in Focus
☀️Trending News JOHNSON & JOHNSON ($NYSE:JNJ) (JNJ) is one of the most iconic companies in the world. A healthcare giant, [...]
Scilex Holding Stock Fair Value – SCILEX FILES For $500m Mixed Securities Shelf Offering
☀️Trending News Scilex Holding ($NASDAQ:SCLX) Inc. has filed for a $500 million mixed securities shelf offering. Scilex has several drug [...]
FDA Denies Full Approval for Amgen’s Lung Cancer Drug Lumakras
🌧️Trending News AMGEN INC ($NASDAQ:AMGN) is a global biopharmaceutical company that discovers, develops, manufactures and delivers innovative human therapeutics. Recently, [...]
Pfizer Inc dividend calculator – Pfizer Yields 5.92% Following 2.4% Dividend Increase: Here’s Why Investors Should Buy In
☀️Trending News Pfizer Inc ($NYSE:PFE)., one of the world's largest pharmaceutical companies, has recently announced a 2.4% dividend increase which [...]
